InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 461 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
What is InfuSystem Holdings Inc (INFU)'s P/E Ratio?
The P/E ratio of InfuSystem Holdings Inc is 27.4388
Who is the CEO of InfuSystem Holdings Inc?
Ms. Carrie Lachance is the President of InfuSystem Holdings Inc, joining the firm since 2019.
What is the price performance of INFU stock?
The current price of INFU is $10.16, it has decreased 0% in the last trading day.
What are the primary business themes or industries for InfuSystem Holdings Inc?
InfuSystem Holdings Inc belongs to Health Care industry and the sector is Health Care
What is InfuSystem Holdings Inc market cap?
InfuSystem Holdings Inc's current market cap is $205.0M
Is InfuSystem Holdings Inc a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for InfuSystem Holdings Inc, including 3 strong buy, 7 buy, 1 hold, 0 sell, and 3 strong sell